An AI designed a vaccine — and it just passed its first human trial. 🧬 UK researchers used AI to build a 'super-antigen' (pEVAC-PS) targeting many coronaviruses at once. In 39 volunteers it was safe and triggered broad immunity — against COVID, the original SARS, and bat viruses with pandemic potential. The shift: AI going from generating text to designing molecules that work in the body. What should AI design next? 👉 www.contentbuffer.com #AI #Biotech #DrugDiscovery #AINews